Well that is all very well for you, based on the assumption you are an investor whom entered into CXS only after the free fall collapse last year. I am sure you have some form of gratitude and loyalty to this group of lacklustre Australian biotech managers.
Many of us whom have held strong conviction in the company over many years, further being reassured from management post FDA rejection, brought in at levels of around $1 or 70c.
Most of us reading this post, I am sure, have held onto this company for more than 12 months, without anything promising nor spectacular, only to find a dead end. It's to the effect of, "here is your money back, if you are lucky, without any real explanation of why this is happening or reason for the self-evident dishonesty over the past 12 months."
The TRUE investors of this company I have no doubt feel the same, but they just want to exit with minimal loss or minimal profit. More to the point, it's the duration investors have been in CXS, driven by false hope that hits our objection. We have every right in condemning the management of Chemgenex and in particular Greg Collier, whom in my eyes, is least rewarding of even a single option he received this year.
The "conjecture", as to put it, is VERY much deserved and the end result will prove it.
IN conclusion, the TRUE investors of this company, and YES, I mean the common everyday shareholder, will have been screwed over and I personally will NEVER, ever, in my lifetime, invest in any Australian BioTech company again.
Add to My Watchlist
What is My Watchlist?